Li Tieqiang1, Jan-Erik Juto1, Karin Sandek2, and Daniel Alamidi3
1Department of Medical Radiation and Nuclear Medicine, Karolinska university Hospital, Huddinge, Sweden, 2Capio S:t Göran, Stockholm, Sweden, 3The Royal Insititute of Technlogy, Huddinge, Sweden
Synopsis
Chronic
obstructive pulmonary disease (COPD) is
currently the third leading mortality cause in the world. There is
neither a reliable blood biomarkers to confirm its diagnosis nor curative treatment. In this study we tested the hypothesis that the lung
function and cerebrovascular responsiveness for COPD patients may be altered by
a novel therapy through restoration of ANS homeostasis along with the
improvement of clinical symptoms.
Introduction
Chronic obstructive pulmonary
disease (COPD) is a heterogeneous lung
disease characterized by chronic obstruction of lung airflow
that is not fully reversible. COPD is currently the third leading mortality cause in
the world. There
is neither a reliable blood biomarkers to confirm its diagnosis nor curative treatment. COPD is usually associated
with systemic inflammation and dysfunction of the autonomic nervous system
(ANs)1,2. We have recently
developed a non-invasive nerve stimulation technique through the nasal cavity,
which function as a homeostasis restoration (HOMER) has been shown to have
therapeutic efficacy for COPD and other chronic inflammatory diseases3,4. In this study we tested
the hypothesis that the lung function and cerebrovascular responsiveness for
COPD patients may be altered by the HOMER therapy through restoration of ANS
homeostasis along with the improvement of clinical symptoms. Methods
Nine
patients (female/male=4/5, aged 59-79 years old) clinically diagnosed as having
moderate degree of COPD symptoms (grade 2-3) were recruited into the study. All
patients received at least 10 HOMER treatments over a period of 3 weeks. Each
treatment lasted for about 20 min (10 min for each side of the nasal cavities)
as described previously. The subjects underwent clinical assessment by COPD
medical expert and MRI examinations both before and within one week after the
completion of the HOMER treatment. The clinical evaluations included the
followings (1) quality of life according to COPD assessment test (CAT); (2) Six
minutes walking test (6MWT); (3) spirometry measurements. The MRI protocol
included (1) T1 mappings of the lung under air and enhanced oxygen conditions;
(2) Functional imaging of the brain using a block-designed hyperoxia paradiam
which lasted for 12 min consisting of 3 air breathing epochs interleaved with 3
epochs of pure oxygen breathing. Each epoch lasted 2 min. The administration
was O2 accomplished through a MRI compatible facemask.
All MRI data
acquisition was conducted on a whole-body 3T clinical MRI scanner (Ingenia CX,
Philips Medical System) equipped with a 16-channel head coil and 32-channel
body array coil. A multiple flip angle UTE protocol was selected for T1-mapping
of the lung5, 6. For the fMRI
study of the brain a single-shot 2D GRE-EPI pulse sequence was used to acquire
a 12 min time series of GRE fMRI dataset during hyperoxia paradigm described
above. The main acquisition parameters for the R-fMRI datasets were the
followings: 41 axial oblique slices of 3 mm thick, TR/TE=2000/30 ms, , matrix
size=80x80, flip angle=75°, parallel acceleration factor=2.
The
MRI datasets underwent a standard preprocessing procedure7, which was performed with AFNI and FSL
(http://www.fmrib.ox.ac.uk/fsl) programs with a bash wrapper shell. The first 5 timeframes
in each dataset were removed to ensure signal steady state. After de-spiking,
six-parameter rigid body image registration was performed for motion
correction. The average volume for each motion-corrected time series was used
to generate a brain mask to minimize the inclusion of the extra-cerebral
tissue. Spatial normalization to the Montreal Neurological Institute (MNI)
standard-space T1-weighted average structural template image was performed
using a 12-parameter affine transformation and mutual-information cost
function. Nuisance signal removal was performed by voxel-wise regression using
14 regressors based on the motion correction parameters, average signal of the
ventricles and their 1st order derivatives. After removing baseline trend up to
the third order polynomial, effective band-pass filtering was performed using
low-pass filtering at 0.08 Hz. Local Gaussian smoothing up to FWHM = 4 mm was
performed using an eroded gray matter mask. The correlation coefficient (CC)for
the fMRI time course and hyperoxia paradigm was computed voxel wise. The paired
t-test was used to assess the CC alteration before and after HOMER treatments. Statistical significance was assessed with an initial cluster-forming voxel-wise
threshold of p<0.001 and
model-free randomized permutation simulation was used to estimate the corrected
family-wise error rate (FWER) for the clusters.Results
As shown in
Fig. 1, 8/9 patients had improved CAT
score following 10 HOMER treatments in 3 weeks and the average improvement in
CAT score was 29%. 6/9 patients had increased talking distance in 6MWT
evaluation. The average increase was 4.5% corresponding to 18 meters. May inhance the CBF response to hyperoxia. As shown in Fig. 2, only very
few limited brain regions including the precuneus, Para hippocampal gyrus, and
lentiform nucleus had altered cerebrovascular responsiveness to hyperoxia. As
illustrated in Fig. 3, almost all subjects (except for one) demonstrated change
from nearly non-responsiveness to vasodilation to hyperoxia instead of
vasoconstriction. Conclusion
The
preliminary results from this pilot study indicate that HOMER treatment that
has clinical efficacy may alter cerebrovascular responsiveness to
hyperoxia for COPD patients. Acknowledgements
No acknowledgement found.References
1. Bernardo,
A.F., L.C. Vanderlei, and D.M. Garner, HRV
Analysis: A Clinical and Diagnostic Tool in Chronic Obstructive Pulmonary
Disease. Int Sch Res Notices, 2014. 2014:
p. 673232.
2. Chhabra,
S.K., et al., Cardiac Sympathetic
Dominance and Systemic Inflammation in COPD. COPD, 2015. 12(5): p. 552-9.
3. Li,
T.Q., et al., Resting-state fMRI study of
acute migraine treatment with kinetic oscillation stimulation in nasal cavity.
Neuroimage Clin, 2016. 12: p. 451-9.
4. Juto,
J.E. and R. Hallin, Kinetic oscillation
stimulation as treatment of acute migraine. A randomized, controlled pilot
study. Headache, 2015. 55: p.
11.
5. Alamidi,
D.F., et al., T1 Relaxation Time in Lungs
of Asymptomatic Smokers. PLoS One, 2016. 11(3): p. e0149760.
6. Alamidi,
D.F., et al., COPD Patients Have Short
Lung Magnetic Resonance T1 Relaxation Time. COPD, 2016. 13(2): p. 153-9.
7. Wang,
Y. and T.Q. Li, Analysis of whole-brain
resting-state FMRI data using hierarchical clustering approach. PLoS One,
2013. 8(10): p. e76315.